Peng Yang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- Extracellular vesicles in disease
- Circular RNAs in diseases
- Cancer-related gene regulation
- RNA Interference and Gene Delivery
Papers in
-
- Extracellular vesicles in disease 8
- Advanced biosensing and bioanalysis techniques 8
- RNA Interference and Gene Delivery 8
- Circular RNAs in diseases 6
- RNA modifications and cancer 5
- CRISPR and Genetic Engineering 5
-
- MicroRNA in disease regulation 6
- Co-authors
- Chuanbing Tang (11 shared papers)Parasmani Pageni (9 shared papers)Junwei Tang (5 shared papers)Ranran Chen (5 shared papers)Tianyu Zhu (6 shared papers)Yueming Sun (5 shared papers)Wen Peng (4 shared papers)Chaofan Peng (8 shared papers)
- Journals
- Advanced Science (5 papers)Journal of Experimental & Clinical Cancer Research (4 papers)Clinical and Translational Medicine (3 papers)Nano Today (3 papers)Tumor Biology (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Peng Yang
77 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 127
- Cancer Research 619
- Molecular Biology 1.4k
- Molecular Medicine 68
- Biomaterials 146
- Biomedical Engineering 416
Countries citing papers authored by Peng Yang
This map shows the geographic impact of Peng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Yang more than expected).
Fields of papers citing papers by Peng Yang
This network shows the impact of papers produced by Peng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Yang. The network helps show where Peng Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Peng Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 311 | |
| 2 | 2018 | 211 | |
| 3 | 2020 | 196 | |
| 4 | 2022 | 118 | |
| 5 | 2017 | 100 | |
| 6 | 2021 | 82 | |
| 7 | 2019 | 70 | |
| 8 | 2018 | 68 | |
| 9 | 2020 | 55 | |
| 10 | 2021 | 54 | |
| 11 | 2011 | 50 | |
| 12 | 2022 | 44 | |
| 13 | 2021 | 43 | |
| 14 | 2021 | 42 | |
| 15 | 2021 | 40 | |
| 16 | 2020 | 39 | |
| 17 | 2022 | 39 | |
| 18 | 2023 | 39 | |
| 19 | 2013 | 38 | |
| 20 | 2018 | 37 |
About Peng Yang
Peng Yang is a scholar working on Molecular Biology, Cancer Research, Organic Chemistry, Pharmaceutical Science and Microbiology, having authored 80 papers that have together received 2.5k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (8 papers), Advanced biosensing and bioanalysis techniques (8 papers), RNA Interference and Gene Delivery (8 papers), MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (6 papers), RNA modifications and cancer (5 papers), CRISPR and Genetic Engineering (5 papers) and Antimicrobial agents and applications (5 papers). The work is most often cited by research in Cancer Research (619 citations), Molecular Biology (1.4k citations), Molecular Medicine (68 citations), Biomaterials (146 citations) and Biomedical Engineering (416 citations). Peng Yang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Chuanbing Tang, Parasmani Pageni, Junwei Tang, Ranran Chen, Tianyu Zhu, Yueming Sun, Wen Peng, Chaofan Peng, Jiangzhou Ji and Yuqian Tan. Their work appears in journals such as Advanced Science, Journal of Experimental & Clinical Cancer Research, Clinical and Translational Medicine, Nano Today and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.